{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:42:29Z","timestamp":1786642949268,"version":"build-2736575974"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008562","name":"University of Texas at Austin","doi-asserted-by":"publisher","award":["$1,200,000"],"award-info":[{"award-number":["$1,200,000"]}],"id":[{"id":"10.13039\/100008562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) increases cardiovascular risk, but the vascular benefits of reducing hepatic triglycerides remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine whether short-term diet-induced reductions in hepatic triglycerides improve arterial stiffness and endothelial function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a two-week, two-arm pre-post dietary intervention trial, adults with MASLD or elevated risk were assigned to either a low-carbohydrate (&lt;30 g carbohydrate\/day, n\u2009=\u200924) or low-calorie diet (~1,200\u22121,500 kcal\/day, n\u2009=\u200923). Hepatic triglyceride content was assessed using proton density fat fraction magnetic resonance imaging. Vascular assessments included arterial stiffness as assessed by pulse wave velocity (PWV), and endothelial function via brachial artery flow-mediated dilation (FMD). The Framingham Risk Score (FRS) was evaluated pre- and post-intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, 31 of 47 participants had MASLD. In the total sample, hepatic triglyceride content decreased by 15% relative to baseline (p\u2009&lt;\u20090.001), with no significant differences between the two diet groups. Brachial-ankle PWV decreased by 41 cm\/s (p\u2009=\u20090.001). FRS decreased (p\u2009&lt;\u20090.001) and FMD (p\u2009=\u20090.030) increased by ~1.0% in absolute terms. Reductions in hepatic triglyceride content were positively correlated with changes in heart rate at rest (r\u2009=\u20090.49, p\u2009=\u20090.001), even after the adjustment of age and body weight change (r\u2009=\u20090.35, p\u2009=\u20090.021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vascular function improvements and cardiovascular risk reductions occurred along with hepatic triglyceride reduction following a two-week dietary intervention. Changes in hepatic triglyceride content were positively correlated with the corresponding changes in heart rate but not with measures of vascular function. (ClinicalTrials.gov, NCT05216796).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0345338","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:25:51Z","timestamp":1786641951000},"page":"e0345338","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of short-term reduction in hepatic triglycerides on vascular health in adults with or at risk of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-8749","authenticated-orcid":true,"given":"Tianyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1686-2134","authenticated-orcid":true,"given":"Isabelle","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Caillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha A.","family":"Alhalimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-6576","authenticated-orcid":true,"given":"Natalie N.","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Knight-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreana P.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1780-7471","authenticated-orcid":true,"given":"Hirofumi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"pone.0345338.ref001","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"ZM Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"pone.0345338.ref002","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"ME Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0345338.ref003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.1017","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Disease","volume":"17","author":"EM Przybyszewski","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"1","key":"pone.0345338.ref004","doi-asserted-by":"crossref","DOI":"10.1186\/s43066-024-00348-1","article-title":"Endothelial dysfunction and cardiovascular risk in non-alcoholic fatty liver disease \u2013 a systematic review and meta-analysis","volume":"14","author":"N Toke","year":"2024","journal-title":"Egypt Liver Journal"},{"issue":"9","key":"pone.0345338.ref005","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000000909","article-title":"Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"29","author":"V Jaruvongvanich","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"pone.0345338.ref006","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000108","article-title":"American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease","volume":"7","author":"JG Stine","year":"2023","journal-title":"Hepatol Commun"},{"issue":"11","key":"pone.0345338.ref007","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep4.1765","article-title":"Poor Awareness of Liver Disease Among Adults With NAFLD in the United States","volume":"5","author":"SA Alqahtani","year":"2021","journal-title":"Hepatol Commun"},{"issue":"3","key":"pone.0345338.ref008","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO)","year":"2024","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0345338.ref009","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction","volume":"93","author":"JD Browning","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"pone.0345338.ref010","article-title":"Pulse Wave Velocity in Atherosclerosis","volume":"6","author":"HL Kim","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"pone.0345338.ref011","doi-asserted-by":"crossref","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine","volume":"21","author":"JH Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"issue":"30","key":"pone.0345338.ref012","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/eurheartj\/ehz350","article-title":"Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans","volume":"40","author":"DHJ Thijssen","year":"2019","journal-title":"Eur Heart J"},{"key":"pone.0345338.ref013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.clinbiochem.2007.05.009","article-title":"Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons","volume":"40","author":"M Vogeser","year":"2007","journal-title":"Clin Biochem"},{"issue":"18","key":"pone.0345338.ref014","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"PW Wilson","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"pone.0345338.ref015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials","volume":"68","author":"C Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"pone.0345338.ref016","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","article-title":"Flow-Mediated Dilation and Cardiovascular Event Prediction","volume":"57","author":"DJ Green","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"pone.0345338.ref017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12933-024-02326-8","article-title":"Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial","volume":"23","author":"E Vrentzos","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"pone.0345338.ref018","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.114.305200","article-title":"Nonalcoholic Fatty Liver Disease and Vascular Function","volume":"35","author":"MT Long","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"pone.0345338.ref019","doi-asserted-by":"crossref","first-page":"107249","DOI":"10.1016\/j.vph.2023.107249","article-title":"Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis","volume":"154","author":"B Zhu","year":"2024","journal-title":"Vascul Pharmacol"},{"key":"pone.0345338.ref020","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"J Heeren","year":"2021","journal-title":"Mol Metab"},{"issue":"1","key":"pone.0345338.ref021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12944-020-01250-6","article-title":"The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review","volume":"19","author":"S Talebi","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"2","key":"pone.0345338.ref022","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/medicina58020299","article-title":"Atherosclerosis development and progression: the role of atherogenic small, dense LDL","volume":"58","author":"J Vekic","year":"2022","journal-title":"Medicina"},{"issue":"5","key":"pone.0345338.ref023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019140","article-title":"Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study","volume":"10","author":"H Ikezaki","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"pone.0345338.ref024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2014.07.017","article-title":"Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver","volume":"438","author":"K Kikkawa","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"10","key":"pone.0345338.ref025","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3390\/cells9102258","article-title":"Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation","volume":"9","author":"KL Diehl","year":"2020","journal-title":"Cells"},{"issue":"7","key":"pone.0345338.ref026","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory Mechanisms Contributing to Endothelial Dysfunction","volume":"9","author":"P Theofilis","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"pone.0345338.ref027","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","article-title":"The degree of hepatic steatosis associates with impaired cardiac and autonomic function","volume":"70","author":"D Houghton","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0345338.ref028","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/jc.2009-2801","article-title":"Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities","volume":"95","author":"CMM Licht","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"pone.0345338.ref029","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/liv.15556","article-title":"Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank","volume":"43","author":"O Jamialahmadi","year":"2023","journal-title":"Liver Int"},{"issue":"17","key":"pone.0345338.ref030","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1113\/JP277994","article-title":"Liver sympathetic denervation reverses obesity-induced hepatic steatosis","volume":"597","author":"C Hurr","year":"2019","journal-title":"J Physiol"},{"issue":"8","key":"pone.0345338.ref031","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00535-016-1304-z","article-title":"Hepatic vagus nerve regulates Kupffer cell activation via \u03b17 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis","volume":"52","author":"T Nishio","year":"2017","journal-title":"J Gastroenterol"},{"issue":"2","key":"pone.0345338.ref032","article-title":"Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: Biological sex matters","volume":"80","author":"Heart-Liver Axis Research Collaboration","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0345338.ref033","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.atherosclerosis.2012.05.022","article-title":"Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms","volume":"223","author":"JN Cooper","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"pone.0345338.ref034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/ATVBAHA.114.304798","article-title":"Effect of weight loss on pulse wave velocity: systematic review and meta-analysis","volume":"35","author":"KS Petersen","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:25:58Z","timestamp":1786641958000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345338"}},"subtitle":[],"editor":[{"given":"Aleksandra","family":"Klisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345338","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}